TABLE 2.

Pathophysiology involved in bowel ischaemia

Author	Year	Type	Purpose of study	Place of study	Conclusion
Singh B et al 22	2021	Letter to the editor	To identify the possible mechanisms and diagnostic pathways for AMI in Severe Coronavirus‐19 infection.	USA	Detailed understanding of the occurrence of AMI in COVID‐19 patients will aid in carrying out appropriate diagnostic tests at an early stage and making swift decisions regarding the intensity of thromboprophylaxis to decrease the risk of morbidity and mortality
Rodriguez N et al 23	2020	Case report and literature review	2 cases of COVID‐19‐induced ischaemia leading to acute mesenteric thrombosis. The SCARE criteria have been utilised to report the work in the study	Mexico	Suspicion for rare pathologies like mesenteric thrombosis in COVID‐19 should be raised in patients who present with an unclear clinical picture
Parry A et al 24	2020	Letter to the editor	To identify the possible mechanisms and diagnostic pathways for AMI in Severe Coronavirus‐19 infection	India	Suitable diagnostic tests at an early stage of COVID‐19 can be helpful in making swift decisions regarding the intensity of thromboprophylaxis to decrease the risk of morbidity and mortality linked with the disorder
Ignat M et al 25	2020	Case series	To describe the clinical and the CT features of 3 patients presenting with an acute abdomen induced by SARS‐CoV‐2 infection	France	If a patient with COVID‐19 worsens and the cause is undetermined, abdominal CT can be considered. Exploratory laparotomy and bowel resection may be deemed necessary in the event of small bowel involvement
Paul T et al 26	2020	Case report		Qatar	Severe COVID‐19 pneumonia should raise concern for a hypercoagulable state. Diagnosing and treating such patients early in the disease course has shown better outcomes